Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis
- PMID: 19432953
- PMCID: PMC2684071
- DOI: 10.1186/1748-717X-4-14
Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis
Abstract
Background: To evaluate the impact of four different rectum contouring techniques and rectal toxicities in patients with treated with 3D conformal radiotherapy (3DCRT).
Methods: Clinical and dosimetric data were evaluated for 94 patients who received a total dose 3DCRT of 70 Gy, and rectal doses were compared in four different rectal contouring techniques: the prostate-containing CT sections (method 1); 1 cm above and below the planning target volume (PTV) (method 2); 110 mm starting from the anal verge (method 3); and from the anal verge to the sigmoid flexure (method 4). The percentage of rectal volume receiving RT doses (30-70 Gy) and minimum, mean rectal doses were assessed.
Results: Median age was 69 years. Percentage of rectal volume receiving high doses (>or= 70 Gy) were higher with the techniques that contoured smaller rectal volumes. In methods 2 and 3, the percentage of rectal volume receiving >or= 70 Gy was significantly higher in patients with than without rectal bleeding (method 2: 30.8% vs. 22.5%, respectively (p = 0.03); method 3: 26.9% vs. 18.1%, respectively (p = 0.006)). Mean rectal dose was significant predictor of rectal bleeding only in method 3 (48.8 Gy in patients with bleeding vs. 44.4 Gy in patients without bleeding; p = 0.02).
Conclusion: Different techniques of rectal contouring significantly influence the calculation of radiation doses to the rectum and the prediction of rectal toxicity. Rectal volume receiving higher doses (>or= 70 Gy) and mean rectal doses may significantly predict rectal bleeding for techniques contouring larger rectal volumes, as was in method 3.
Similar articles
-
Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?Br J Radiol. 2017 Feb;90(1070):20160370. doi: 10.1259/bjr.20160370. Epub 2016 Dec 12. Br J Radiol. 2017. PMID: 27936891 Free PMC article.
-
Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.Strahlenther Onkol. 2006 May;182(5):277-82. doi: 10.1007/s00066-006-1462-7. Strahlenther Onkol. 2006. PMID: 16673061
-
Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?Cancer J. 2002 Jan-Feb;8(1):62-6. doi: 10.1097/00130404-200201000-00011. Cancer J. 2002. PMID: 11895204
-
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. doi: 10.1016/j.ijrobp.2004.12.052. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029785 Review.
-
Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.Urology. 2005 Jan;65(1):114-9. doi: 10.1016/j.urology.2004.08.037. Urology. 2005. PMID: 15667875 Review.
Cited by
-
Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer.Strahlenther Onkol. 2012 Sep;188(9):816-22. doi: 10.1007/s00066-012-0126-z. Epub 2012 May 23. Strahlenther Onkol. 2012. PMID: 22614029 Clinical Trial.
-
Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?Br J Radiol. 2017 Feb;90(1070):20160370. doi: 10.1259/bjr.20160370. Epub 2016 Dec 12. Br J Radiol. 2017. PMID: 27936891 Free PMC article.
-
Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer.Rep Pract Oncol Radiother. 2024 Mar 18;29(1):10-20. doi: 10.5603/rpor.99358. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39165591 Free PMC article.
-
The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.J Appl Clin Med Phys. 2024 Jan;25(1):e14179. doi: 10.1002/acm2.14179. Epub 2023 Nov 27. J Appl Clin Med Phys. 2024. PMID: 38013636 Free PMC article.
-
Predictive Factors for Gastrointestinal and Genitourinary Toxicities in Prostate Cancer External Beam Radiotherapy: A Scoping Review.Diagnostics (Basel). 2025 May 26;15(11):1331. doi: 10.3390/diagnostics15111331. Diagnostics (Basel). 2025. PMID: 40506902 Free PMC article. Review.
References
-
- Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427–435. - PubMed
-
- Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys. 2008;71:1028–1033. - PubMed
-
- Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol. 2002;75:151–161. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical